<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01880541</url>
  </required_header>
  <id_info>
    <org_study_id>IB2009-71</org_study_id>
    <nct_id>NCT01880541</nct_id>
  </id_info>
  <brief_title>Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer</brief_title>
  <acronym>HYPNOSEIN</acronym>
  <official_title>Assessment of Cognitive Function After Surgery in Two Types of Anesthesia (General Anesthesia Hypnosedation or Traditional) in Patients Operated for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Bergonié</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The emergence of cognitive disorders after surgery under general anesthesia (GA) is the&#xD;
      second leading cause of patient complaints (after dental debris caused by intubation&#xD;
      techniques). These cognitive disorders can range from simple reversible confusion (26%) with&#xD;
      postoperative cognitive dysfunction without actual recovery (10%).&#xD;
&#xD;
      The hypnosedation is an ancient technique of anesthesia expanding its effects on cognitive&#xD;
      function remain to this day unknown, but appear promising.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For twenty years, hypnosedation is offered to patients who underwent surgery as an&#xD;
      alternative to other anesthetic techniques (general anesthesia and locoregional), in some&#xD;
      European and Anglo-Saxon hospitals for specific surgical indications (surgery area). It is&#xD;
      commonly used in some hospitals.&#xD;
&#xD;
      The hypnosedation is little used in oncology&#xD;
&#xD;
      The hypnosedation is a hypnosis technique suitable for anesthesia, namely the one associated&#xD;
      with intravenous conscious sedation and local anesthesia hypnosis. This derived from medical&#xD;
      hypnosis Ericksoniene technique is divided into three stages:&#xD;
&#xD;
        1. induction&#xD;
&#xD;
        2. Deepening trance&#xD;
&#xD;
        3. Déhypnotisation.&#xD;
&#xD;
      This technique is currently being validated and used at national and international level, in&#xD;
      fact it is based on 500 references and appears in the national nomenclature of the Common&#xD;
      Classification of Medical Procedures in the code ANRP 001, states: hypnosis referred to&#xD;
      analgesic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluating the evolution of cognitive function in patients treated with surgery for breast cancer according to the type of anesthesia chosen by the patient</measure>
    <time_frame>at time of surgery</time_frame>
    <description>Evaluation of cognitive impairment in a series of neuropsychological tests validated : questionnaire for subjective cognitive complaint cognitive and memory test Grober and Buschke, attentional tests and tests of executive functions for cognitive objectives.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess patient characteristics according to the type of anesthesia used</measure>
    <time_frame>1 year</time_frame>
    <description>Assess patient characteristics (physiological, psychological and sociocultural) according to the type of anesthesia used, to identify characteristics predictive of choice of hypnosedation.&#xD;
Depending on the type of anesthesia, evaluated before and after surgery: pain, anxiety level and patient satisfaction with regard to the anesthetic technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depending on the type of anesthesia: pain, anxiety level and patient satisfaction with regard to the anesthetic technique.</measure>
    <time_frame>at time of surgery</time_frame>
    <description>Pain and patient satisfaction will be evaluated by a numerical scale and emotional state by the HAD scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Patients With Breast Cancer and Breast Surgery Requiring</condition>
  <arm_group>
    <arm_group_label>hypnosedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hypnosedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>general anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypnosedation</intervention_name>
    <description>hypnosedation</description>
    <arm_group_label>hypnosedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>general anesthésia</intervention_name>
    <description>general anesthesia</description>
    <arm_group_label>general anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female, over 18 and under 80 years&#xD;
&#xD;
          -  Diagnosis of breast cancer established (Pathology)&#xD;
&#xD;
          -  Life expectancy greater than 6 months&#xD;
&#xD;
          -  Surgery of breast lumpectomy with or without lymph node dissection, mastectomy with or&#xD;
             without lymph node dissection, dissection isolated&#xD;
&#xD;
          -  ASA 1 (healthy patient) or 2 (patient with moderate to high function) according to the&#xD;
             classification of the American Society of Anesthesiologist,&#xD;
&#xD;
          -  Affiliation to a social security scheme,&#xD;
&#xD;
          -  Information on the study, signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of major psychiatric disorders or psychotic behavior addiction, evaluated by&#xD;
             neuropsychologist at the first preoperative consultation, through the test MINI (MINI&gt;&#xD;
             4 positive responses for each module)&#xD;
&#xD;
          -  Presence of neurological disorders known untreated or evaluated by neuropsychologist&#xD;
             at the first preoperative consultation, with the MMSE test (MMSE &lt;24)&#xD;
&#xD;
          -  Patient treated morphine orally for 3 months or more&#xD;
&#xD;
          -  Patient is pregnant or nursing, or of childbearing potential and not using adequate&#xD;
             contraception,&#xD;
&#xD;
          -  Patient included in another clinical study&#xD;
&#xD;
          -  Inability to undergo medical monitoring study for geographical, social or&#xD;
             psychological&#xD;
&#xD;
          -  Patient deprived of liberty and most subject to a measure of legal protection or&#xD;
             unable to consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>COLOMBANI Sylvie, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut Bergonié</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>COLOMBANI Sylvie, MD</last_name>
    <email>s.colombani@bordeaux.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MATHOULIN PELISSIER Simone, PU-PH</last_name>
    <email>s.mathoulin@bordeaux.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DAHLET Christian, MD</last_name>
    </contact>
    <investigator>
      <last_name>DAHLET Christian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <state>Aquitaine</state>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>COLOMBANI Sylvie, MD</last_name>
      <email>s.colombani@bordeaux.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>COLOMBANI Sylvie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HAMDANI Agnès, MD</last_name>
    </contact>
    <investigator>
      <last_name>HAMDANI Agnès, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 6, 2012</study_first_submitted>
  <study_first_submitted_qc>June 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2013</study_first_posted>
  <last_update_submitted>November 26, 2020</last_update_submitted>
  <last_update_submitted_qc>November 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patients with breast cancer and breast surgery requiring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

